pacritinib
cti biopharma
['mpnsm', 'pacritinib', 'persist-2', '#mpn']
congress| #asco23 | helen ajufo from presented analyzed data from the persist-2 trial showing that spleen volume reduction is associated with a survival benefit in pts with mf treated on pacritinib but not on best available therapy #mpnsm #medicalcongress 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm